Use of Monte Carlo Simulations To Select Therapeutic Doses and Provisional Breakpoints of BAL9141

BAL9141, a new antimicrobial agent belonging to the class of parenteral pyrrolidinone-3-ylidenemethyl cephalosporins, is active against most gram-positive microorganisms, including methicillin-resistant variants (methicillin-resistant Staphylococcus aureus [MRSA] and methicillin-resistant Staphyloco...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mouton, Johan W., Schmitt-Hoffmann, Anne, Shapiro, Stuart, Nashed, Norman, Punt, Nieko C.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2004
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC400534/
https://ncbi.nlm.nih.gov/pubmed/15105125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1713-1718.2004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires